Charles River Laboratories
Charles River Laboratories International, Inc., commonly known as Charles River, is a leading provider of essential products and services for the pharmaceutical and biotechnology industries. Headquartered in the United States, the company operates extensively across North America, Europe, and Asia, offering a global reach that enhances its service delivery. Founded in 1947, Charles River has achieved significant milestones, including the expansion of its preclinical and clinical services. The company specialises in drug discovery, safety assessment, and laboratory services, providing unique solutions that streamline the research process. Its commitment to innovation and quality has solidified its position as a trusted partner in the life sciences sector. With a robust portfolio that includes in vivo and in vitro testing, Charles River Laboratories is recognised for its expertise and reliability, making it a preferred choice for organisations seeking to advance their research and development efforts.
DitchCarbon Score
How does Charles River Laboratories's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Charles River Laboratories's score of 51 is higher than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Charles River Laboratories's reported carbon emissions
In 2023, Charles River Laboratories reported total greenhouse gas (GHG) emissions of approximately 90002000 kg CO2e for Scope 1 and about 45976000 kg CO2e for Scope 2, with Scope 3 emissions reaching approximately 423884000 kg CO2e. This reflects a commitment to reducing absolute Scope 1 and 2 GHG emissions by 50% by 2030, using 2018 as a baseline, and a 15% reduction in Scope 3 emissions by 2030, based on 2019 levels. Over the years, Charles River has demonstrated a proactive approach to climate commitments. In 2019, their emissions were approximately 91609000 kg CO2e for Scope 1 and about 78003000 kg CO2e for Scope 2, alongside significant Scope 3 emissions of around 334829000 kg CO2e. By 2022, they reported approximately 89005000 kg CO2e for Scope 1 and about 42266000 kg CO2e for Scope 2, with Scope 3 emissions increasing to about 395537000 kg CO2e. The company has set ambitious targets, including increasing the sourcing of renewable electricity from 1% in 2018 to 100% by 2030. These targets align with the Science Based Targets initiative (SBTi) and are consistent with efforts to limit global warming to 1.5°C. Charles River Laboratories is committed to transparency and accountability in its climate strategy, aiming for substantial reductions across all scopes of emissions by 2030.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|
| Scope 1 | 86,284,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 79,271,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | 000,000,000 | - | 000,000,000 | 000,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Charles River Laboratories is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
